| European Case Law Identifier: | ECLI:EP:BA:2002:T085402.20021014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 October 2002 | ||||||||
| Case number: | T 0854/02 | ||||||||
| Application number: | 93401978.7 | ||||||||
| IPC class: | A61K 31/335 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of taxol for the manufacture of a medicament for the treatment of cancer | ||||||||
| Applicant name: | BRISTOL-MYERS SQUIBB COMPANY | ||||||||
| Opponent name: | NaPro BioTherapeutics Inc Boehringer Ingelheim GmbH BAKER NORTON PHARMACEUTICALS, INC, |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Not adversely affected opponent - appeal inadmissible | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t020854eu1.html
Date retrieved: 17 May 2021